Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


PAF receptor ligand
BML-L137-0001 1 mg 88.00 USD
BML-L137-0005 5 mg 362.00 USD
Do you need bulk/larger quantities?
PAF receptor antagonist. Inhibits PAF-induced human platelet and neutrophil aggregation in vitro (IC50=0.17 and 0.36µM respectively). In vivo it dose dependently blocks eosinophil activation and displays antiallergic and anti-inflammatory activity in various models. Induces differentiation and triggers apoptosis and in a variety of cell lines.

Product Specification

Purity:≥98% (HPLC)
Identity:Determined by 1H-NMR.
Appearance:Beige solid.
Solubility:Soluble in DMSO or ethanol.
Long Term Storage:+4°C
Handling:Store dessicated.
Please mouse over

Product Literature References

WEB-2086 and WEB-2170 trigger apoptosis in both ATRA-sensitive and -resistant promyelocytic leukemia cells and greatly enhance ATRA differentiation potential: A. Laurenzana, et al.; Leukemia 19, 390 (2005), Abstract;
Apafant, a potent platelet-activating factor antagonist, blocks eosinophil activation and is effective in the chronic phase of experimental allergic conjunctivitis in guinea pigs: M. Kato, et al.; J. Pharmacol. Sci. 95, 435 (2004), Abstract;
Platelet-activating factor induces lung inflammation and leak in rats: hydrogen peroxide production along neutrophil-lung endothelial cell interfaces: Y.M. Lee, et al.; J. Lab. Clin. Med. 140, 312 (2002), Abstract;
Specific PAF antagonist WEB-2086 induces terminal differentiation of murine and human leukemia cells: C. Cellai, et al.; FASEB J. 16, 733 (2002), Abstract; Full Text
Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor: J. Casals-Stenzel, et al.; J. Pharmacol. Exp. Ther. 241, 974 (1987), Abstract;

Related Literature

Technical Posters
Arachidonic Acid Metabolites
Arachidonic Acid Metabolites
Download as PDF

All new literature pieces

Recommend this page

For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2018 Enzo Life Sciences, Inc.,